ABCB1基因多态性及其对轻度认知障碍认知衰退的贡献:下一代测序研究
Omar Šerý1,2, Kateřina Sheardová3,4, Radka Dziedzinska1,2
1Laboratory of Neurobiology and Molecular Psychiatry, Department of Biochemistry, Faculty of Science, Masaryk University, Brno, Czech Republic.
概括
某些ABCB1基因变异与轻度认知障碍患者的语言衰退有关. 这些遗传变化可能会影响基因功能和阿尔茨海默病的进展.
科学领域:
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 该ABCB1基因对于清除粉样β和运输胆固醇至关重要,这表明它参与了阿尔茨海默氏病的发病过程.
- 轻度认知障碍 (MCI) 是阿尔茨海默病的先驱,了解其进展对于早期干预至关重要.
研究的目的:
- 研究ABCB1基因多态化与MCI患者的认知衰退,特别是语言功能之间的关联.
- 探索潜在的分子机制,这些机制是ABCB1多态对认知表现的影响的基础.
主要方法:
- 来自捷克大脑衰老研究的1005名参与者 (包括AD,MCI,主观认知衰退和对照) 的纵向队列研究.
- 下一代测序来分析整个ABCB1基因和综合的神经心理测试来评估认知功能,包括语言.
- 在 silico 分析中预测识别的多形态对基因表达和调节的功能影响.
主要成果:
- 十种ABCB1多态性与认知表现有显著的关联,特别是在amnestic MCI患者的语言下降.
- 在基分析表明,一些多态可能会改变转录因子结合部位和外显拼接增强剂生成.
- 一种多态性 (rs55912869) 被确定为微RNA hsa-mir-3163.3 的潜在结合部位.
结论:
- 在患有amnestic MCI的个体中,ABCB1基因多态性在认知衰退,特别是语言障碍中发挥着重要作用.
- 这些多态可能通过与microRNAs,转录因子和替代拼接的相互作用影响认知功能,影响ABCB1基因表达和功能.
- 这些发现表明,ABCB1多形态是预测认知衰退的潜在生物标志物,也是MCI和阿尔茨海默病的治疗标.
更多相关视频
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
14.8K
04:22Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
742
相关概念视频
01:26Alzheimer's Disease: Overview
412
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
412
01:28Human Genetics
510
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
510
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
88
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
88
01:22Alzheimer's Disease: Treatment
142
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
142